These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 20021522)

  • 1. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial.
    Al-Khatib SM; Piccini JP; Knight D; Stewart M; Clapp-Channing N; Sanders GD
    J Cardiovasc Electrophysiol; 2010 May; 21(5):545-50. PubMed ID: 20021522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.
    Heidbüchel H; Lioen P; Foulon S; Huybrechts W; Ector J; Willems R; Ector H
    Europace; 2008 Mar; 10(3):351-7. PubMed ID: 18245771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
    Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
    Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study.
    Varma N
    Am Heart J; 2007 Dec; 154(6):1029-34. PubMed ID: 18035071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a remote monitoring system for implantable cardioverter defibrillators.
    Masella C; Zanaboni P; Di Stasi F; Gilardi S; Ponzi P; Valsecchi S
    J Telemed Telecare; 2008; 14(6):290-4. PubMed ID: 18776073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost savings and safety of ICD remote control by telephone: a prospective, observational study.
    Bikou O; Licka M; Kathoefer S; Katus HA; Bauer A
    J Telemed Telecare; 2010; 16(7):403-8. PubMed ID: 20870684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database.
    Lazarus A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S2-S12. PubMed ID: 17302706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of CRT-ICD: implications for the use of remote follow-up systems. Data from the InSync ICD Italian Registry.
    Lunati M; Gasparini M; Santini M; Landolina M; Perego GB; Pappone C; Marzegalli M; Argiolas C; Murthy A; Valsecchi S;
    Pacing Clin Electrophysiol; 2008 Jan; 31(1):38-46. PubMed ID: 18181908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
    Kuhl EA; Sears SF; Vazquez LD; Conti JB
    J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial.
    Varma N; Michalski J; Epstein AE; Schweikert R
    Circ Arrhythm Electrophysiol; 2010 Oct; 3(5):428-36. PubMed ID: 20716717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.
    Crossley GH; Chen J; Choucair W; Cohen TJ; Gohn DC; Johnson WB; Kennedy EE; Mongeon LR; Serwer GA; Qiao H; Wilkoff BL;
    J Am Coll Cardiol; 2009 Nov; 54(22):2012-9. PubMed ID: 19926006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study.
    Crossley G; Boyle A; Vitense H; Sherfesee L; Mead RH
    Am Heart J; 2008 Nov; 156(5):840-6. PubMed ID: 19061696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies?
    Papavasileiou LP; Forleo GB; Panattoni G; Schirripa V; Minni V; Magliano G; Bellos K; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):114-9. PubMed ID: 22644407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) study: rationale and design.
    Burri H; Quesada A; Ricci RP; Boriani G; Davinelli M; Favale S; Da Costa A; Kautzner J; Moser R; Navarro X; Santini M
    Am Heart J; 2010 Jul; 160(1):42-8. PubMed ID: 20598971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.
    Varma N; Epstein AE; Irimpen A; Schweikert R; Love C;
    Circulation; 2010 Jul; 122(4):325-32. PubMed ID: 20625110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes.
    Forleo GB; Tesauro M; Panattoni G; Della Rocca DG; Papavasileiou LP; Sergi D; Di Molfetta A; Santini L; Romeo F
    Heart; 2012 Mar; 98(5):402-7. PubMed ID: 22115985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the MONITOR-ICD study: a randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with Implantable Cardioverter Defibrillators.
    Zabel M; Müller-Riemenschneider F; Geller JC; Brachmann J; Kühlkamp V; Dissmann R; Reinhold T; Roll S; Lüthje L; Bode F; Eckardt L; Willich SN;
    Am Heart J; 2014 Oct; 168(4):430-7. PubMed ID: 25262251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.